Skip to main content

Call for papers - Personalised Medicine and Gene Therapy

Guest Editor:
William Cho: Queen Elizabeth Hospital, Hong Kong

Submission Status: Open   |   Submission Deadline: 27 January 2024


© © Maksim Shmeljov / stock.adobe.comBMC Medical Genomics is calling for submissions to our collection on "personalised medicine and gene therapy". Personalised medicine aims at improving both diagnostics and treatment outcomes for patients, with more accurate diagnostics and very specific treatment for the conditions diagnosed. Research in the genetic causes of diseases provides increasing insight into causes and pathways of disease. With a better understanding of genetic causes and pathways, more accurate and personalised diagnostics and treatment options for a variety of different conditions can be developed.

Meet the Guest Editor

Back to top

William Cho: Queen Elizabeth Hospital, Hong Kong

Dr. Cho’s main research interests have been focusing on cancer studies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. As a seasoned researcher, Dr Cho has conducted cancer research in using molecular biology, proteomics, genomics, immunology as well as bioinformatics.  Dr Cho published extensively with hundreds of peer-reviewed papers (Lancet, Lancet Oncology, Annals of Oncology, Lancet Gastroenterology & Hepatology, Advanced Science, Nature Communications, PNAS, Molecular Cancer, Journal of Thoracic Oncology, Journal of Extracellular Vesicles, Clinical Cancer Research, Clinical Chemistry, etc) covering cancer biomarkers, proteomics, non-coding RNAs. Dr Cho is listed in the world's top 2% most influential scientists.


About the collection

© © Maksim Shmeljov / stock.adobe.comBMC Medical Genomics is calling for submissions to our collection on "personalised medicine and gene therapy". Personalised medicine aims at improving both diagnostics and treatment outcomes for patients, with more accurate diagnostics and very specific treatment for the conditions diagnosed. Research in the genetic causes of diseases provides increasing insight into causes and pathways of disease. With a better understanding of genetic causes and pathways, more accurate and personalised diagnostics and treatment options for a variety of different conditions can be developed. The profound understanding of the genetic underpinnings of disease enables highly specific treatment options such as gene therapy. 

This collection welcomes submissions of research on personalised diagnostics and treatments, including gene therapy. For diagnostic tools, especially bioinformatics studies on biomarkers, the potential of clinical applications should be demonstrated by validation in independent clinical cohorts. 


Image credit: Maksim Shmeljov / stock.adobe.com

  1. Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common autosomal dominant genetic diseases. Whole exome sequencing (WES) is a routine tool for diagnostic confirmation of genetic disease...

    Authors: Peiwen Xu, Lijuan Wang, Jing Li, Sexin Huang, Ming Gao, Ranran Kang, Jie Li, Hongqiang Xie, Xiaowei Liu, Junhao Yan, Xuan Gao and Yuan Gao
    Citation: BMC Medical Genomics 2023 16:285
    Content type: Research Published on:

  2. Colorectal cancer is a malignant tumor that poses a serious threat to human health. The main objective of this study is to investigate the mechanism by which Jatrorrhizine (JAT), a root extract from Stephania Epi...

    Authors: Lingyu Huang, Yu Sha, Wenken Liang, Chune Mo, Chunhong Li, Yecheng Deng, Weiwei Gong, Xianliang Hou and Minglin Ou
    Citation: BMC Medical Genomics 2023 16:217
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles. Before submitting your manuscript, please ensure you have read our submission guidelines. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Personalised Medicine and Gene Therapy" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.